BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 9372207)

  • 1. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala.
    Bakshi VP; Newman SM; Smith-Roe S; Jochman KA; Kalin NH
    J Neurosci; 2007 Sep; 27(39):10568-77. PubMed ID: 17898228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
    Oliveira LA; Almeida J; Benini R; Crestani CC
    Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission.
    Liu J; Yu B; Neugebauer V; Grigoriadis DE; Rivier J; Vale WW; Shinnick-Gallagher P; Gallagher JP
    J Neurosci; 2004 Apr; 24(16):4020-9. PubMed ID: 15102917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain.
    Brunson KL; Grigoriadis DE; Lorang MT; Baram TZ
    Exp Neurol; 2002 Jul; 176(1):75-86. PubMed ID: 12093084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
    Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
    Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of corticotropin releasing factor(CRF) on somatic pain sensitivity in conscious rats: involvement of CRF1 and CRF2 receptors].
    Iarushkina NI; Bagaeva TR; Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2014 Nov; 100(11):1287-96. PubMed ID: 25665407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses.
    Ji G; Fu Y; Adwanikar H; Neugebauer V
    Mol Pain; 2013 Feb; 9():2. PubMed ID: 23410057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
    Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
    J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
    Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
    J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
    Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ
    Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study.
    Bagosi Z; Jászberényi M; Szabó G; Telegdy G
    Brain Res Bull; 2008 Jan; 75(1):15-7. PubMed ID: 18158090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
    Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.